Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes

Environmental Toxicology and Pharmacology

Volumn 35, Issue 2, 2013, Pages 254-264

  Bielawski, Krzysztof ^a   Czarnomysy, Robert ^a   Muszyńska, Anna ^a   Bielawska, Anna ^a   Popławska, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Breast cancer cell; Cisplatin; Cytotoxicity; Dinuclear platinum complex; Flow cytometry

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PLATINUM 2 (3 BUTYLPYRIDINE) 4 (BERENIL) 2; PLATINUM 2 (3 ETHYLPYRIDINE) 4 (BERENIL) 2; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOASSAY; BREAST CANCER; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DNA FRAGMENTATION; DNA STRAND BREAKAGE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPOPHILICITY; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CISPLATIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ORGANOPLATINUM COMPOUNDS;

EID: 84873802557     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.12.010     Document Type: Article

References (28)

1. Bielawska A., Popławska B., Surazyński A., Czarnomysy R., Bielawski K. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells. Eur. J. Pharmacol. 2010, 643:34-41.
2. Bielawski K., Bielawska A., Popławska B., Bołkun-Skórnicka U. Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands. Acta Pol. Pharm. Drug Res. 2008, 65:363-370.
3. Brabec V., Kasparkova J. Modifications of DNA by platinum complexes: relation to resistance of tumors to platinum antitumor drugs. Drug Resist. Updat. 2005, 8:131-146.
4. Blanc C., Deveraux Q.L., Krajewski S. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res. 2000, 60:4386-4390.
5. Brunelle J.K., Zhang B. Apoptosis assays for quantifying the bioactivity of anticancer drug products. Drug Resist. Updat. 2010, 13:172-179.
6. Carmichael J., Degraff W., Gazdar A., Minna J., Mitchell J. Evaluation of a tetrazolinium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47:936-942.
7. Cohen J.J., Duke R.C., Fadok V.A., Sellins K.S. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 1992, 10:267-293.
8. Coward P., Wada H.G., Falk M.S., Chan S.D.H., Meng F., Akil H., Conklin B.R. Controlling signaling with a specifically designed Gi-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:352-357.
9. Farrell N. Polynuclear platinum drugs. Metal Ions in Biological Systems 2004, 251-296. Marcel Dekker, Inc., New York, Basel. A. Sigel, H. Sigel (Eds.).
10. Fuertes M.A., Alonso C., Perez J.M. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem. Rev. 2003, 103:646-662.
11. Gandara D.R., Perez E.A., Philips W.A., Lawrence H.J., DeGregoria M. Evaluation of cisplatin dose intensity: current status and future prospects. Anticancer Res. 1989, 9:1121-1128.
12. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
13. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Emerging role of caspase-3 in apoptosis. Cell Death Differ. 1999, 6:99-104.
14. Kumar S. Caspase function in programmed cell death. Cell Death Differ. 2007, 14:32-43.
15. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential(deltapsi(m)) in apoptosis. Apoptosis 2003, 8:116-128.
16. Mangrum J.B., Farrell N.P. Excursions in polynuclear platinum DNA binding. Chem. Commun. (Camb). 2010, 46:6640-6650.
17. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995, 182:1545-1556.
18. Muchova T., Quintal S.M., Nicholas P., Farrell N.P., Brabec V., Kasparkova J. Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions. J. Biol. Inorg. Chem. 2012, 17:239-245.
19. Rebillard A., Jouan-Lanhouet S., Jouan E., Legembre P., Pizon M., Sergent O., Gilot D., Tekpli X., Lagadic-Gossmann D., Dimanche-Boitrel M.T. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells. Eur. J. Cancer 2010, 46:1445-1455.
20. Russo M., Mupo A., Spagnuolo C., Russo G.L. Exploring death receptor pathways as selective targets in cancer therapy. Biochem. Pharmacol. 2010, 80:674-682.
21. Singh S.K., Moretta D., Almaguel F., Wall N.R., De Leon M., De Leon D. Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells. Growth Factors 2007, 25:363-372.
22. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
23. Smith I.E., Talbot D.C. Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br. J. Cancer 1992, 65:787-793.
24. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhabitable by Bcl-2. Cell 1994, 79:329-339.
25. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995, 184:39-51.
26. Westermann B. Molecular machinery of mitochondrial fusion and fission. J. Biol. Chem. 2008, 283:13501-13505.
27. Wheate N.J., Collins J.G. Multi-nuclear platinum drugs: a new paradigm in chemotherapy. Curr. Med. Chem. Anticancer Agents 2005, 5:267-279.
28. Yang S., Zhou Q., Yang X. Caspase-3 status is a determinant of differential responses to genistein between MD-MB-231 and MCF-7 breast cancer cells. Biochim. Biophys. Acta 2007, 1773:903-911.